← Eichor
Condition: Immunoglobulin A Nephropathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunoglobulin A Nephropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · 18 location(s) · Regeneron Pharmaceuticals · NCT06975787Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT07585981Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Phase 3 · 9 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07390123Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT05510323Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Phase 1/Phase 2 · 9 location(s) · Eledon Pharmaceuticals · NCT05027906Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07010250A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07104721Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
NA · 1 location(s) · Botkin Hospital · NCT07056595A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT06952426M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid
Phase 1 · 5 location(s) · EMD Serono Research & Development Institute, Inc. · NCT07166601A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Phase 3 · 251 location(s) · Biogen · NCT06935357A Study of SHR-2173 in Participants With Primary IgA Nephropathy
Phase 2 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07354932Correlation of Microbiome and Metabonomics With IgA Nephropathy
Phase N/A · 5 location(s) · Guangdong Provincial People's Hospital · NCT05190848A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
EARLY_Phase 1 · 1 location(s) · Nanjing Bioheng Biotech Co., Ltd. · NCT07203404CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07305116A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With
Phase 2 · 17 location(s) · Shanghai Henlius Biotech · NCT07038382PS-002 for the Treatment of IgA Nephropathy in Adults
Phase 1/Phase 2 · 10 location(s) · Purespring Therapeutics Limited · NCT07182227Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Phase 3 · 8 location(s) · ZHOU FANGJIAN · NCT05738694Effective Dosing of Burosumab in XLH
Phase N/A · 1 location(s) · University of Nottingham · NCT07183579A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Phase 3 · 13 location(s) · The University of Queensland · NCT05325008Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary
Phase 3 · 6 location(s) · Novartis Pharmaceuticals · NCT07498335A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Ex
Phase 1/Phase 2 · 5 location(s) · Kidney Cancer Research Bureau · NCT07292168A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patient
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT06676007A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · 172 location(s) · Takeda · NCT06963827Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2 · 47 location(s) · Travere Therapeutics, Inc. · NCT05003986Raman Spectroscopy Diagnosis of Kidney Diseases
Phase N/A · 1 location(s) · Zunsong Wang · NCT06760845Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06792799Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07507201
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.